Viewing Study NCT00259103


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-01-27 @ 5:27 PM
Study NCT ID: NCT00259103
Status: COMPLETED
Last Update Posted: 2014-05-07
First Post: 2005-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor
Sponsor: Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: RLX.CR.001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators